Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

87 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Paclitaxel and gemcitabine vs. paclitaxel and pegylated liposomal doxorubicin in advanced non-nasopharyngeal head and neck cancer. An efficacy and cost analysis randomized study conducted by the Hellenic Cooperative Oncology Group.
Fountzilas G, Papakostas P, Dafni U, Makatsoris T, Karina M, Kalogera-Fountzila A, Maniadakis N, Aravantinos G, Syrigos K, Bamias A, Christodoulou C, Economopoulos T, Kalofonos H, Nikolaou A, Angouridakis N, Stathopoulos G, Bafaloukos D, Pavlidis N, Daniilidis J. Fountzilas G, et al. Among authors: makatsoris t. Ann Oncol. 2006 Oct;17(10):1560-7. doi: 10.1093/annonc/mdl151. Epub 2006 Jun 21. Ann Oncol. 2006. PMID: 16790517 Free article. Clinical Trial.
Pegylated liposomal doxorubicin hydrochloride (PLD) and paclitaxel in recurrent or metastatic head and neck carcinoma: a phase I/II study conducted by the Hellenic Cooperative Oncology Group (HeCOG).
Janinis J, Stathopoulos GP, Nikolaidis P, Kalofonos HP, Kalogera-Fountzila A, Samantas E, Aravantinos G, Anagnostopoulos A, Tolis C, Makatsoris T, Rigatos SK, Bafaloukos D, Dimopoulos MA, Daniilidis J, Fountzilas G. Janinis J, et al. Among authors: makatsoris t. Anticancer Drugs. 2004 Jun;15(5):479-87. doi: 10.1097/01.cad.0000127662.81719.86. Anticancer Drugs. 2004. PMID: 15166622 Clinical Trial.
Treatment of non-small cell lung cancer with gefitinib ('Iressa', ZD1839): the Greek experience with a compassionate-use program.
Razis E, Skarlos D, Briasoulis E, Dimopoulos M, Fountzilas G, Lambropoulos S, Rigatos S, Kopterides P, Efstathiou H, Tzamakou E, Bakoyannis C, Pectasides D, Makatsoris T, Varthalitis G, Papadopoulos S, Kosmidis P. Razis E, et al. Among authors: makatsoris t. Anticancer Drugs. 2005 Feb;16(2):191-8. doi: 10.1097/00001813-200502000-00011. Anticancer Drugs. 2005. PMID: 15655417
Induction chemotherapy with cisplatin, epirubicin, and paclitaxel (CEP), followed by concomitant radiotherapy and weekly paclitaxel for the management of locally advanced nasopharyngeal carcinoma. A Hellenic Cooperative Oncology Group phase II study.
Fountzilas G, Tolis C, Kalogera-Fountzila A, Karanikiotis C, Bai M, Misailidou D, Samantas E, Athanassiou E, Papamichael D, Tsekeris P, Catodritis N, Nicolaou A, Plataniotis G, Makatsoris T, Papakostas P, Zamboglou N, Daniilidis J. Fountzilas G, et al. Among authors: makatsoris t. Strahlenther Onkol. 2005 Apr;181(4):223-30. doi: 10.1007/s00066-005-1355-1. Strahlenther Onkol. 2005. PMID: 15827691 Clinical Trial.
A phase II study of capecitabine plus oxaliplatin (XELOX): a new first-line option in metastatic colorectal cancer.
Makatsoris T, Kalofonos HP, Aravantinos G, Papadimitriou C, Kastritis E, Rigatos SK, Xiros N, Petsas T, Economopoulos T, Sakadamis AK, Fountzilas G; Hellenic Cooperative Oncology Group. Makatsoris T, et al. Int J Gastrointest Cancer. 2005;35(2):103-9. doi: 10.1385/ijgc:35:2:103. Int J Gastrointest Cancer. 2005. PMID: 15879624 Clinical Trial.
Phase I study of etoposide, cisplatin and irinotecan triplet in patients with advanced-stage small-cell lung cancer.
Briasoulis E, Samantas E, Kalofonos H, Skarlos D, Makatsoris T, Christodoulou C, Fountzilas G, Bamias A, Dimopoulos MA, Kosmidis P, Pavlidis N. Briasoulis E, et al. Among authors: makatsoris t. Cancer Chemother Pharmacol. 2005 Nov;56(5):521-8. doi: 10.1007/s00280-004-0994-8. Epub 2005 Jun 15. Cancer Chemother Pharmacol. 2005. PMID: 15959778 Clinical Trial.
Combination of topotecan and cisplatin in relapsed patients with small cell lung cancer: a phase II study of the hellenic cooperative oncology group (HeCOG).
Christodoulou C, Kalofonos HP, Briasoulis E, Bafaloukos D, Makatsoris T, Koutras A, Skarlos DV, Samantas E. Christodoulou C, et al. Among authors: makatsoris t. Cancer Chemother Pharmacol. 2006 Jan;57(2):207-12. doi: 10.1007/s00280-005-0034-3. Epub 2005 Jul 19. Cancer Chemother Pharmacol. 2006. PMID: 16028103 Clinical Trial.
87 results